Translate this page into:
Diffuse Liver Uptake of Tc-99M Mdp from Renal Cell Carcinoma Metastases. a Case Report and Review of Literature
Correspondence to: Sree KumarA MD DNB DRM Associate Professor of Nuclear Medicine Regional Cancer Centre Medical College PO, Trivandrum-695011
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Scintigraphy with Technetium-99m methylene diphosphonate (MDP) delineates a wide spectrum of nonosseous disorders. 99mTechnetium-methylene diphosphonate (MDP) bone isotope may accumulate in many extraosseous sites due to variety of both benign and malignant conditions. Neoplastic, hormonal, inflammatory, ischemic, traumatic, excretory, and artifactual entities demonstrate abnormal soft-tissue uptake of Tc-99m MDP. Mechanisms leading to increased extraosseous Tc-99m MDP uptake includes extracellular fluid expansion, enhanced regional vascularity and permeability, and elevated tissue calcium concentration. Usually metastases in the liver shows focal rather than diffuse uptake of Tc-99m MDP. Recognition of these modes of extraskeletal Tc-99m MDP uptake can enhance the diagnostic value of bone scintigraphy.
